Javascript must be enabled to continue!
The prophylactic role of tamsulosin in preventing of postoperative urinary retention in rectal cancer patients
View through CrossRef
Abstract
Purpose
We designed a prospective study to evaluate the efficiency of tamsulosin, a selective alpha adrenergic antagonist, on development of postoperative urinary retention.
Methods
A total of 100 rectal cancer patients who underwent elective surgery in Department of Surgery of Tehran university Hospital, were included in this study. Patients were classified into one of two groups. In control group, the patients were not received tamsulosin. Patients in tamsulosin group were prescribed 0.4 mg of tamsulosin orally, 14 hours and 2 hours before surgery and postoperatively until patient is discharged orally.
Results
47 patients were included in control group and 53 in tamsulosin group. Although the incidence of postoperative urinary retention was lower in the tamsulosin group than other (11.32% vs 17.02%), but no significant difference was found (p = 0.24).
Conclusions
This prospective study showed that tamsulosin at 0.4 mg/day does not prevent postoperative urinary retention in rectal cancer patients.
Research Square Platform LLC
Title: The prophylactic role of tamsulosin in preventing of postoperative urinary retention in rectal cancer patients
Description:
Abstract
Purpose
We designed a prospective study to evaluate the efficiency of tamsulosin, a selective alpha adrenergic antagonist, on development of postoperative urinary retention.
Methods
A total of 100 rectal cancer patients who underwent elective surgery in Department of Surgery of Tehran university Hospital, were included in this study.
Patients were classified into one of two groups.
In control group, the patients were not received tamsulosin.
Patients in tamsulosin group were prescribed 0.
4 mg of tamsulosin orally, 14 hours and 2 hours before surgery and postoperatively until patient is discharged orally.
Results
47 patients were included in control group and 53 in tamsulosin group.
Although the incidence of postoperative urinary retention was lower in the tamsulosin group than other (11.
32% vs 17.
02%), but no significant difference was found (p = 0.
24).
Conclusions
This prospective study showed that tamsulosin at 0.
4 mg/day does not prevent postoperative urinary retention in rectal cancer patients.
Related Results
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Current therapeutic strategies for erectile function recovery after radical prostatectomy – literature review and meta-analysis
Radical prostatectomy is the most commonly performed treatment option for localised prostate cancer. In the last decades the surgical technique has been improved and modified in or...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Outcome of Modification of Dose and Time of Administration of Tamsulosin in Men with Abnormal Ejaculation
Outcome of Modification of Dose and Time of Administration of Tamsulosin in Men with Abnormal Ejaculation
<b><i>Introduction:</i></b> Alpha-adrenergic blockers are now the cornerstone medication in management of lower urinary tract symptom (LUTS); however, the a...
Role of low-dose deflazacort with tamsulosin versus tamsulosin alone for medical expulsive therapy of ureteric stone
Role of low-dose deflazacort with tamsulosin versus tamsulosin alone for medical expulsive therapy of ureteric stone
Background: Urolithiasis is a common condition in daily urological practice. Medical Expulsive Therapy (MET) is non-invasive approach for removal of ureteric stone. In MET, alpha-b...
Role of low-dose deflazacort with tamsulosin versus tamsulosin alone for medical expulsive therapy of ureteric stone
Role of low-dose deflazacort with tamsulosin versus tamsulosin alone for medical expulsive therapy of ureteric stone
Background: Urolithiasis is a common condition in daily urological practice. Medical Expulsive Therapy (MET) is non-invasive approach for removal of ureteric stone. In MET, alpha-b...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...

